Not having a bowel movement
Figure 1 shows the serial level for valproic acid and Table 1 shows laboratory test results over days of treatment
GLP-1 therapy requires structured nutritional support to manage metabolic adaptation
As per the US Food and Drug Administration, these weight loss drugs can have side effects such as inflammation of the pancreas (pancreatitis), low blood sugar, allergic reactions, kidney problems (kidney failure), other severe stomach problems, and complications of diabetes-related eye disease (diabetic retinopathy)
This represents an obstacle in current preclinical research, wherein the restricted ability to employ live imaging methods in conjunction with ECoG monitoring hinders the investigation of seizures and SDs in GBM
and Teva Pharmaceutical Ltd